Healthcare Growth Recognized as Healthcare & Life Sciences Law Firm of the Year by Chambers USA in 2026, signaling strong demand and potential cross-sell opportunities in healthcare regulatory, clinical trials, and life sciences industry clients.

Private Equity Need Active expansion in private equity and alternative assets with key hires in New York and Milan, suggesting ongoing demand for fund formation, portfolio company M&A, and compliance services across U.S. and European markets.

DealFlow Enablement Adoption of deal management and client workflow platforms (DealCloud and Celeste via Intapp) indicates openness to technology-enabled services, data analytics, and onboarding solutions that streamline matter intake, risk assessment, and reporting for corporate clients.

Lateral Growth Strong Q1 lateral hiring standout positions the firm for capacity expansion and cross-border practice development; opportunities exist to present talent acquisition support, onboarding acceleration, and integration advisory for clients with growing private equity and corporate work.

Thought Leadership Active industry events such as Rare Disease Forum and broad geographic footprint (U.S., UK, EU, Asia) present opportunities to offer sponsorship packages, custom industry insights, and technology-enabled knowledge platforms to deepen client relationships and attract potential enterprise clients.